Multiple Myeloma | Oncology Today with Dr Neil Love: Recently Approved Agents in Multiple Myeloma

published 2 months ago by Dr Neil Love

Featuring an interview with Dr Joseph Mikhael on the following topics: Recently approved agents for multiple myeloma (MM) (0:00) Case: A man in his mid-70s with standard-risk MM receives isatuximab with pomalidomide and dexamethasone as second-line therapy (22:15) Case: A woman in her mid-70s with high-risk MM receives selinexor and dexamethasone after disease progression on multiple lines of therapy (24:01) Case: A woman in her late 60s experiences keratopathy after treatment with belantamab mafodotin for relapsed/refractory MM (25:31) Consideration of transplant for patients with MM; DREAMM-6 trial evaluating belantamab mafodotin with bortezomib/dexamethasone for relapsed/refractory MM (27:16) CME information and select publications

more episodes from Research To Practice | Oncology Videos